Hepatocyte Growth Factor in Blood and Gastric Cancer Risk: A Nested Case-Control Study.

doi:10.1158/1055-9965.EPI-19-0436

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Hepatocyte Growth Factor in Blood and Gastric Cancer Risk: A Nested Case-Control Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Feb 2020

Jang Jieun, Ma Seung Hyun, Ko Kwang-Pil, Choi Bo Yul, Yoo Keun-Young, Park Sue K

Abstract excerpt

BACKGROUND: Potential of hepatocyte growth factor (HGF)-stimulating signaling pathways related to cytotoxin-associated gene A (CagA) to predict gastric cancer development has not been fully investigated. METHODS: We conducted a nested case-control study consisting of 238 gastric cancer cases and 238 matched controls within the Korean Multicenter Cancer Cohort. Plasma HGF concentrations were measured with a human...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Bacterial
Share to Antigens, Bacterial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Helicobacter Infections

Share to Hepatocyte Growth Factor

Share to Models, Statistical

Share to Proto-Oncogene Proteins c-met

Share to ROC Curve

Share to Stomach Neoplasms

Source

Open in PubMed

Identifiers

PMID: 31740519
DOI: 10.1158/1055-9965.EPI-19-0436

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.